Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Sun Pharmaceutical Industries Limited ( (IN:SUNPHARMA) ) just unveiled an update.
Sun Pharmaceutical Industries Limited has notified the stock exchanges that it has published newspaper advertisements in the Financial Express (all editions) and the Vadodara edition of Loksatta Jansatta, providing information on its unaudited financial results for the quarter and nine months ended 31 December 2025. The company has also made copies of these newspaper clippings available on its website, underscoring its compliance with SEBI’s disclosure regulations and reinforcing transparency for investors and other stakeholders regarding its latest financial performance.
More about Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited is a leading Indian multinational pharmaceutical company engaged in the manufacture and sale of branded and generic formulations and active pharmaceutical ingredients. Headquartered in Mumbai with a registered office in Vadodara, the company focuses on prescription medicines across multiple therapeutic areas and serves both domestic and international markets, with its shares listed on the National Stock Exchange of India and BSE.
Average Trading Volume: 112,515
Technical Sentiment Signal: Hold
Current Market Cap: 3826.8B INR
For a thorough assessment of SUNPHARMA stock, go to TipRanks’ Stock Analysis page.